Last reviewed · How we verify

NCT06665282

Efficacy of Pulsed High Intensity Laser Therapy in Psoriatic Hand Arthritis

Completed NA Last updated 30 October 2024
What this trial tests

NA trial testing Pulsed high intensity laser therapy in High Intensity Laser Therapy in 76 participants. Completed in 1 July 2024.

Timeline
1 August 2023
Primary endpoint
1 May 2024
1 July 2024

Quick facts

Lead sponsorCairo University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment76
Start date1 August 2023
Primary completion1 May 2024
Estimated completion1 July 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 30 to 50, any sex, with High Intensity Laser Therapy or Psoriasis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of the study was to evaluate the therapeutic efficacy of pulsed high intensity level laser therapy in improving symptoms of psoriatic hand arthritis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for High Intensity Laser Therapy

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06665282.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing